Resources

Hospital & Laboratory Services

Client Care is open Monday to Friday 8:30am to 4:30pm EST except for statutory holidays.

Please let us know how we are doing by completing our Client Feedback form. Your feedback is appreciated.

2024-047-Sperm Antibody Itraconazole Amiodarone and Metabolite 2024-046 Labelling packages and TDG 2024-045 Valproic Acid Digoxin and Carnitine Testing_ 2024-043-New VIP-Mayo 2024-040 Streptcoccus Pneumoniae 2024-039 Coagulation Tests Updated Reference Intervals 2024-038 VEGF-D Revision 2024-036 MOG Antibodies-Revised 2024-035 ApoE 2024-033 New EPO Service 2024-032 Oligosaccharides & CDT 2024-031 1,25 - DihydroxyVitamin D Revision 2024-026 Factor XIII Assay (Urea Clot Solubility), Plasma 2024-023-VIP-Mayo 2024-022-Silver-LON 2024-021-Strepto23 2024-020-pTau217 2024-019-BCNeuroimmunology 2024-018-ThyroglobulinAbShift 2024-017-TraceMetals with Table 2024-016 Heart Muscle Antibodies 2024-015 NSCI Revision 2024-013 CD163 revision 2024-012 APCR revision 2024-011 Aldosterone U revision 2024-010 Specimen Packaging 2024-008 Neurology LHSC 2024-007 IGF-1 & Oxalate 2024-005 Neurofilament Light Chain (Nfl) 2024-003 VIP 2024-002 CJD & Prion Diseases 2024-001 ADAMTS-13 2023-060 Quinidine, MTHFR 2023-059 sTfR, CSF Amino Acids 2023-058 CIDP, TPMT 2023-057 Pyruvate, VIP 2023-056 C-peptide, IgLON5, TPMT 2023-055 Procalcitonin 2023-053 Calcitonin 2023-050 A1AT, Infliximab 2023-049 Alzheimer's Disease Biomarkers Panel 2023-048 Trypsin, L-Asparaginase, Cortisol 2023-046 Copeptin 2023-044 Urine Oxalate 2023-042 Methotrexate, Ganglioside GQ1B Ab 2023-041 SRA, PINP, CRP, Urine Drug Screens 2023-039 N-Telopeptide Urine, VIP, Borrelia Miyamotoi Ab 2023-038 Urine Drug Screens 2023-037 Acetaminophen, TRAB, Osteocalcin, Thyroglobulin, Purine and Pyrimidines, Metabolic Screen, Ethylene Glycol 2023-036 N-Telopeptide, PINP 2023-035 New Protocol for UBJ and UPE 2023-033 APOA1, APOB, Lipoprotein a, Histamine 2023-032 NT-ProBNP, BNP 2023-031 Itraconazole, Posaconazole, Tamoxifen 2023-029 Use of Transfer Vials 2023-028 Free Protoporphyrin, Erythrocytes 2023-027 Oxalate 2023-026 Myoglobin 2023-025 Curry IgE, Hop Fruit IgE, Antimony 2023-024 N-Telopeptide, 5HIAA Plasma 2023-023 Infliximab with Reflex Antibodies 2023-022 GM1Ganglioside Ab, DPD Gene Mutation 2023-020 ALP Isoenzymes 2023-019 Lacosamide, Anti-MMP-1 2023-018 GAD65, DHT, Alprazolam 2023-017 25-Hydroxyvitamin D 2023-015 IL-2 Receptor, Mitotane, ZnT8 Antibodies 2023-014 C1q, Immune Complexes, C1INH, Venlafaxine, Neutrophil Ab 2023-013 Fluvoxamine, Glycine Receptor Alpha 1 IgG, Kit D816 Mutation, MIrtazapine 2023-012 IFNB-1, A1AG, A2MG, ACTH, BNP, Everolimus 2023-011 Bile acid, NfL 2023-010 Alpha-Galactosidase, L-Asparaginase 2023-009 Alpha-Galactosidase, Protein C, A1AG, A2MG 2023-008 Alpha-1-Antitrypsin Serum 2023-007 Carotene, Dihydrotestosterone, C6 2023-005 Cholinesterase, Lidocaine, Free T3, Free T4, Hepatitis D, B & E, Urine chemistries 2023-004 NMDA, Adalimumab, Factor XIII, Fibroblast Growth Factor 23 2023-003 Bile Acids 2023-002 C-Telopeptide, Chlordiazepoxide, Oxazepam, Diazepam, Bile Acids, G6PD 2023-001 Myositis, Phytanic Acid, Sterols, G6PD, Factor H 2022-050 Vitamin K, Vitamin B2, Fluoride, Mitotane, PGD2, Phytanic Acid, Sterols, Retinol Binding Protein, A1AT 2022-049 Oxalate Service Disruption 2022-048 Ceruloplasmin, Levetiracetam, Lipoprotein Ultracentrifugation 2022-047 CoQ10, Myositis, HMGCR, Paraneoplastic tests, Autoimmune Enacephalitis 2022-045 Levetiracetam, Infliximab, Cholinesterase, Inhibin, Anti-MAG 2022-044 C-telopeptide, Cholinesterase, PACP 2022-043 Preeclampsia Testing - sFlt-1PLGF Ratio 2022-042 Haptoglobin, Paroxetine, Myositis 2022-041 Tricyclic Antidepressant Drugs 2022-040 sTfR, Trypsin, VEGFD 2022-038 Histone Ab, Warfarin, Prostaglandins, Methylhistamine 2022-037 Vitamin B3, CMV Ab, Drug Screen, Fluoride 2022-035 Amiodarone, Histone Ab, CEA, IGF-1 2022-034 Soluble IL-2R 2022-033 C3-C4 update 2022-032 C2 Complement, Strep Ab, Warfarin, Lactoferrin 2022-031 Anti-MAG, IL-2, Aldosterone/Renin, LD Isoenzymes, A1AT 2022-029 Tricyclics, Neuron Specific Enolase, Estrone, Estradiol 2022-028 Dihydrotestosterone, Cystatin C/eGFR, CK, Lipoprotein a 2022-027 Canadian Diagnostic Executive Forum 2022-025 USDTL, Folate 2022-024 Anti-MAG, Trypsin, C1E Inhibitor, Procalcitonin 2022-023 Clomipramine, Coagulation Factors 2022-021 Chylomicron_Triglyceride Profile 2022-020 LPA 2022-019 ACE 2022-018 Estrone, Adenosine Deaminase, A1AT 2022-017 ARV at McGill 2022-016 Cytokines at HSC 2022-014 Infliximab-EtGluc-Azathio 2022-013 Levetiracetam, A1AT, Xylose Absorption Test 2022-012 Farmer's Lung IgG Antibodies 2022-011-C2, CH50, Lipid profile, Azathioprine, Barbiturates and Sedatives, EtGluc, Olanzapine, Vitamin B3 2022-010 Reporting Revisions 2022-008 A1AT&Cytokines 2022-007 Cystatin C revision 2022-006 Calprotectin revision 2022-004 H pylori revision 2022-003 RandomU TraceMetals LHSC 2021-029-LipaseReagentShortage 2021-025-Serotonin Method Change 2021-024 IFA Assays 2021-021-Catecholamines 2021-020 Porphyrins 2021-019 7-dehydrocholesterol 2021-017 Lipoprotein Ultracentrifugation 2021-015 Porphyrins 2021-012 Autoimmune Encephalitis, PK, Various reference range revisions 2021-011 Progesterone, Estradiol 2021-010 Oligoclonal Banding 2021-009 Metabolic Screen, Purines & Pyrimidines 2021-006 EBV, Vitamins A, B1, B6 and C 2021-005 Hemoglobin Fractionation, Methylmalonic Acid 2021-004 EBV, Immunoglobulin D, C-Telopeptide COVID19-Cumulative-08Feb2021 2021-002-Various 2021-001-Various 2020-044-Various 2020-041-Vitamins 2020-040-Aldosterone 2020-038-Service Interruptions 2020-037-Revisions 2020-035-UCAT 2020-034-Revisions 2020-032-Test Interruptions 2020-031-COVID Diagnostic Testing 2020-029-COVID Interruptions Update 2020-027-ServiceRevisions 2020-026-Communications-COVID 2020-025-Test Interruptions 2020-024-COVID Interruptions-Suppliers 2020-023-COVID Interruptions-Clients 2020-022-CDT, CDT for CDG 2020-020-CoronavirusUpdate 2020-019-DopMet 2020-018-New Tests 2020-017-Newc5b9&Tick 2020-016-Dopamine&Metanephrines 2020-015-Trim,IGFBP3,BioT 2020-014-IGFBP3 2020-013-IgG Index 2020-012 21 Hydroxylase Antibodies 2020-011-NewTests 2020-009-TRAB-TSI 2020-008-Gangliosides Antibodies Profile IgG + IgM 2020-007 Revision - Shipping specimens from patients suspected or confirmed having Coronavirus 2020-005 Coronavirus and specimen pick up and delivery location changes 2020-003-PTHrP&HistaP 2020-002-ADAMTS 2020-001-HMGCRAb 2019-054-NewTests 2019-053-P50 2019-052-NextVarious 2019-050-NextVarious 2019-049-Aminoglycosides 2019-048-NewTests 2019-045-Various 2019-044-Various 2019-043-TestRevisions 2019-042-Various 2019-041-FarmersLung 2019-040-Various 2019-038-Test Revision-Metanephrines, Random Urine Results 2019-035 New Website and Test Catalogue Launch 2019-033-VitaminK 2019-030-Copeptin 2019-029 Canadian Diagnostic Executive Forum 2019-028-Test Delay 2019-025-Various 2019-022 Fecal Immunochemical Test (FIT) 2019-021 Various 2019-019 Various 2019-018-CystatinC 2019-017 Trypsin 2019-015-Various 2019-014-β2 Glycoprotein 1 Antibody 2019-013-Copeptin 2019-012-Metanephrines 2019-010-Various 2019-009-Copeptin&ADH 2019-008-Test Delay 2019-007-Various 2019-005-LRC-Delay 2019-004-BKV-Method 2019-003-Copeptin 2019-002 Follow Up -Labelling Packages the TDG Act and Regs Final 2019-001-Phytanic 2018-051-Labelling Packages the TDG Act and Regs Final 2018-050-Various 2018-048-AvianAntigenSpecificTests 2018-047-AvianPrecipitins 2018-046-Various 2018-045-Homocysteine 2018-044-VitB1 2018-042-Allergens 2018-041-NMO-MOG-SJO 2018-037-Tryptase 2018-036-HSC-Units-Correction 2018-035-Patient Names for Multiple Births 2018-034-Trypsin-Quest 2018-031-UrineCortisolRevision 2018-030-VitaminD 2018-029-ChromograninA 2018-028-Various 2018-027-AcetylcholineRecAb 2018-026-Dihydrotestosterone 2018-025-Glucagon-Mayo 2018-024-Cortisol-Saliva 2018-022-DrugScreenRevision-Epic 2018-021-DrugScreenRevision-Epic 2018-019-TimedCollections 2018-017-VitB1-PL-QST 2018-016-PRCAL-STM-Rev 2018-015-VitB1-WB 2018-014-B2MG-S 2018-013-Amino_Acids 2018-012-Recall 2018-011-RBC_FOL 2018-010-Various 2018-007-25-OH-Vitamin D 2018-005- Alkaline Phosphatase Bone Specific 2018-004-Test Revision-Orotic Acid, Urine - Correction 2018-003-Various-Revisions 2018-002-Test Revision-Orotic Acid, Urine 2018-001-Test Revision-CH50

Please check back soon for up-to-date requisitions. If you have any questions, please email info@iclabs.ca.

Please refer to the links below for guidance for shipping specimens and dangerous goods to ICL.

Please complete the request form below for required supplies and fax or email it to 416-385-1957 or info@iclabs.ca